Compare MRNA & STN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | STN |
|---|---|---|
| Founded | 2010 | 1954 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.3B |
| IPO Year | 2018 | N/A |
| Metric | MRNA | STN |
|---|---|---|
| Price | $51.78 | $101.69 |
| Analyst Decision | Hold | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $32.75 | N/A |
| AVG Volume (30 Days) | ★ 11.8M | 293.2K |
| Earning Date | 02-13-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 0.65% |
| EPS Growth | N/A | ★ 44.12 |
| EPS | N/A | ★ 3.04 |
| Revenue | $2,232,000,000.00 | ★ $4,547,020,941.00 |
| Revenue This Year | N/A | $12.14 |
| Revenue Next Year | $3.18 | $10.00 |
| P/E Ratio | ★ N/A | $32.52 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $22.28 | $73.18 |
| 52 Week High | $50.00 | $114.52 |
| Indicator | MRNA | STN |
|---|---|---|
| Relative Strength Index (RSI) | 82.55 | 63.37 |
| Support Level | $39.21 | $97.42 |
| Resistance Level | $41.98 | $100.65 |
| Average True Range (ATR) | 2.93 | 2.00 |
| MACD | 1.57 | 0.46 |
| Stochastic Oscillator | 87.75 | 93.16 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.